Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Interleukin-6

  • You have access
    EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro
    KUO-LUNG TUNG, YEN-TING WU, CHENG LIU, SHENG-CHIEH LIN, CHIN-HAN WU, SHIH-YI WU, YAO CHANG and YU-YAN LAN
    Anticancer Research June 2020, 40 (6) 3255-3264; DOI: https://doi.org/10.21873/anticanres.14307
  • You have access
    Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway
    SHUICHI IWAHASI, FENG RUI, YUJI MORINE, SHINICHIRO YAMADA, YU SAITO, TETSUYA IKEMOTO, SATORU IMURA and MITSUO SHIMADA
    Anticancer Research February 2020, 40 (2) 743-749; DOI: https://doi.org/10.21873/anticanres.14005
  • You have access
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
    SHENGLING FU and JIAYUH LIN
    Anticancer Research November 2018, 38 (11) 6271-6279; DOI: https://doi.org/10.21873/anticanres.12983
  • You have access
    The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression
    JANA JUREČEKOVÁ, HENRIETA DROBKOVÁ, MIROSLAVA ŠARLINOVÁ, EVA BABUŠÍKOVÁ, MONIKA KMEŤOVÁ SIVOŇOVÁ, TATIANA MATÁKOVÁ, JÁN KLIMENT and ERIKA HALAŠOVÁ
    Anticancer Research June 2018, 38 (6) 3663-3667; DOI: https://doi.org/10.21873/anticanres.12643
  • You have access
    Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer
    TATSUO SHIMURA, MASAHIKO SHIBATA, KENJI GONDA, YASUHIDE KOFUNATO, RYO OKADA, TERUHIDE ISHIGAME, TAKASHI KIMURA, AKIRA KENJO, KOJI KONO and SHIGERU MARUBASHI
    Anticancer Research September 2017, 37 (9) 4979-4986;
  • You have access
    High Interleukin-6 mRNA Expression Is a Predictor of Relapse in Colon Cancer
    JESPER OLSEN, LENE T. KIRKEBY, JØRGEN OLSEN, SUSANNE EIHOLM, PER JESS, ISMAIL GÖGENUR and JESPER T. TROELSEN
    Anticancer Research April 2015, 35 (4) 2235-2240;
  • You have access
    Curcumin and Cancer Stem Cells: Curcumin Has Asymmetrical Effects on Cancer and Normal Stem Cells
    PETER P. SORDILLO and LAWRENCE HELSON
    Anticancer Research February 2015, 35 (2) 599-614;
  • You have access
    Primary Peritoneal Angiosarcoma: A Case Report
    JUAN LITVAN, MARTA AGHAZARIAN, ELIZABETH WILEY, SONIA GULERIA and ARKADIUSZ Z. DUDEK
    Anticancer Research September 2014, 34 (9) 5001-5006;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire